- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Solid Tumors in United Kingdom
Total 11155 results
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
BioNTech SEGenmabRecruitingAdvanced Malignant Solid TumorUnited States, United Kingdom
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Solid TumorsUnited States
-
University of CincinnatiCompletedSolid Tumors | Malignant NeoplasmUnited States
-
Royal Marsden NHS Foundation TrustUniversity College London Hospitals; University of Southampton; St George's University... and other collaboratorsCompletedNeoplasms | Cancer | Tumor | Malignant Neoplasm | End Stage Cancer | Malignancy | Terminal CancerUnited Kingdom
-
SanofiCompletedMalignant Solid TumorsFrance, Spain, United States, Italy
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Ovarian Carcinoma | Pancreatic Neuroendocrine Tumor | Unresectable Solid Neoplasm | Fibrolamellar CarcinomaUnited States
-
Syndax PharmaceuticalsCompletedSolid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic TumorUnited States
-
SanofiTerminatedMalignant Solid TumorFrance, Spain, Australia, Belgium, Italy, United Kingdom, Taiwan, Estonia, Netherlands, Korea, Republic of, United States, Canada, Germany
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Malignant Solid TumorsUnited States
-
University of Southern CaliforniaActive, not recruiting
-
Onconova Therapeutics, Inc.CompletedSolid Tumors | Malignant NeoplasmasUnited States
-
PharmaMarCompletedAdvanced Malignant Solid TumorsSpain, United States
-
Immorna Biotherapeutics, Inc.Active, not recruitingMalignant Solid Tumor | Cutaneous TumorUnited States
-
PfizerRoswell Park Cancer Institute; South Texas Accelerated Research Therapeutics...CompletedAdvanced Malignant Solid TumorsUnited States
-
Peregrine PharmaceuticalsTerminatedMalignant Solid TumorUnited States
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
ImmunityBio, Inc.CompletedMalignant Solid TumourUnited States
-
SCRI Development Innovations, LLCNovartisCompletedSolid Tumors | Refractory MalignancyUnited States
-
SCRI Development Innovations, LLCNovartisCompletedMalignant Solid TumourUnited States
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Zai Lab (Hong Kong), Ltd.Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.RecruitingMalignant Solid TumorUnited States, Spain, China
-
University of PittsburghBristol-Myers SquibbCompletedMalignant Solid TumourUnited States
-
The University of Texas Health Science Center at...Merck Sharp & Dohme LLCCompleted
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
Formation BiologicsUnknownMalignant Solid TumorUnited States, Canada
-
Mateon TherapeuticsCancer Research UKCompleted
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
University of California, San FranciscoHyundai Hope On WheelsCompletedMalignant Solid Tumor | Childhood Solid TumorUnited States
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Ikena OncologyActive, not recruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States